|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.030 USD | -3.52% |
|
-6.51% | -31.63% |
| 05-07 | Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| 05-06 | Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026 | CI |
Chart calendar Vanda Pharmaceuticals Inc.
Upcoming events on Vanda Pharmaceuticals Inc.
No events available
Past events on Vanda Pharmaceuticals Inc.
| 04/06/2026 | Présentation aux Actionnaires / Analystes | 14:00 |
| 04/06/2026 | Annual General Meeting | 14:00 |
| 06/05/2026 | Earnings release - Q1 2026 | |
| 06/05/2026 | Earnings presentation | 21:30 |
| 11/02/2026 | Earnings presentation | 21:30 |
| 11/02/2026 | Earnings release - Q4 2025 | |
| 29/10/2025 | Earnings release - Q3 2025 | |
| 29/10/2025 | Earnings presentation | 20:30 |
| 31/07/2025 | Earnings presentation | 13:00 |
| 31/07/2025 | Earnings release - Q2 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 193 184 4.47% | 199 199 -0.34% | 216 218 -0.95% | 263 | 356 | 432 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,0 -18,4 24.17% | -40,7 -38,4 -5.99% | -151 -143 -5.64% | -150 | -67,3 | -50,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6,34 2,60 143.81% | -22,9 -21,8 -5.38% | -139 -127 -8.74% | -142 | -63,0 | -46,0 |
|
Net income Million USD | Released Forecast Spread | 2,51 -0,50 601.8% | -18,9 -18,7 -0.96% | -220 -158 -39.8% | -140 | -62,3 | -44,7 |
|
EPS USD | Released Forecast Spread | 0,04 -0,01 500% | -0,33 -0,32 -3.13% | -3,74 -2,67 -39.94% | -2,31 | -0,88 | -0,63 |
| Announcement Date | 07/02/24 | 13/02/25 | 11/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 47,7 49,2 -3.06% | 53,2 52,3 1.79% | 50,0 45,1 10.87% | 52,6 54,8 -3.97% | 56,3 58,7 -4.21% | 57,2 59,3 -3.47% | 51,7 52,9 -2.23% | 61,8 | 69,2 | 80,0 | 78,7 | 87,2 | 91,5 | 97,0 |
|
EBIT Million USD | Released Forecast Spread | -11,0 -14,8 25.44% | -10,3 -10,4 0.94% | -41,0 -42,0 2.35% | -38,5 -25,3 -52.36% | -31,3 -34,6 9.58% | -40,4 -32,2 -25.19% | -50,2 -52,7 4.61% | -39,2 | -34,8 | -26,1 | -28,1 | -17,4 | -12,3 | -5,57 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,24 -10,2 38.83% | -6,50 -6,94 6.37% | -37,4 -35,3 -5.82% | -34,9 -21,5 -62.27% | -28,4 -28,0 -1.31% | -38,0 -26,7 -42.12% | -48,4 -44,9 -7.92% | -36,9 | -32,8 | -23,9 | -27,3 | -16,9 | -11,8 | -5,12 |
|
Net income Million USD | Released Forecast Spread | -5,32 -9,54 44.21% | -4,91 -6,33 22.43% | -29,5 -35,0 15.84% | -27,2 -21,1 -28.74% | -22,6 -27,0 16.42% | -141 -78,2 -80.46% | -48,6 -44,4 -9.46% | -36,5 | -31,9 | -22,9 | -27,3 | -16,9 | -11,9 | -5,59 |
|
EPS USD | Released Forecast Spread | -0,09 -0,16 44.9% | -0,08 -0,11 27.27% | -0,50 -0,60 16.2% | -0,46 -0,36 -28.97% | -0,38 -0,45 16.18% | -2,39 -1,33 -80.38% | -0,82 -0,69 -19.27% | -0,61 | -0,52 | -0,38 | -0,35 | -0,21 | -0,13 | -0,05 |
| Announcement Date | 06/11/24 | 13/02/25 | 07/05/25 | 31/07/25 | 29/10/25 | 11/02/26 | 06/05/26 | - | - | - | - | - | - | - |
| 08/06/2026 |  | Présentation aux Actionnaires / Analystes | |
| 08/06/2026 | | Information meeting | 03:00 |
| 08/06/2026 | | Board of Directors Meeting | |
| 08/06/2026 | | Présentation aux Actionnaires / Analystes | 14:00 |
| 08/06/2026 | | Annual General Meeting | |
| 09/06/2026 | | Annual General Meeting | |
| 09/06/2026 | | Présentation aux Actionnaires / Analystes | 18:30 |
| 09/06/2026 | | Annual General Meeting | |
| 09/06/2026 | | Présentation aux Actionnaires / Analystes | 14:00 |
| 09/06/2026 | | Annual General Meeting |
Past sector events for Vanda Pharmaceuticals Inc.
| Today | | Extraordinary General Meeting | |
| 05/06/2026 | | Présentation aux Actionnaires / Analystes | 16:00 |
| 05/06/2026 | | Annual General Meeting | 16:00 |
| 05/06/2026 | | Annual General Meeting | 06:30 |
| 05/06/2026 | | Annual General Meeting | 19:00 |
| 05/06/2026 | | Présentation aux Actionnaires / Analystes | 19:00 |
| 05/06/2026 | | Annual General Meeting | 02:00 |
| 05/06/2026 | | Annual General Meeting | 14:00 |
| 05/06/2026 | | Présentation aux Actionnaires / Analystes | 14:00 |
| 04/06/2026 | | Annual General Meeting | 17:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VNDA Stock
- Calendar Vanda Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition